SG3 Management’s Acceleron Pharma XLRN Stock Holding History

SG3 Management’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-95,000	Closed	-$16.4M	–	1412
2021 Q3	$16.4M	Buy	+95,000	New	+$12.4M	0.5%	31
2020 Q4	–	Sell	-15,000	Closed	-$1.69M	–	1289
2020 Q3	$1.69M	Sell	15,000 -15,000	-50%	-$1.49M	0.06%	307
2020 Q2	$2.86M	Buy	+30,000	New	+$2.89M	0.2%	137

SG3 Management's XLRN Position: Q4 2021 in Review

SG3 Management sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 60,000 shares — an estimated $10.3M sold.

SG3 Management first reported a position in XLRN in Q3 2021 and held it in 1 quarter. The position peaked at $10.3M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

SG3 Management reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
SG3 Management sold 60,000 Acceleron Pharma shares in Q4 2021, an estimated $10.3M.
SG3 Management first reported a position in Acceleron Pharma in Q3 2021 and held it in 1 quarter.
SG3 Management's Acceleron Pharma position peaked at $10.3M in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on SG3 Management's 13F filing for Q4 2021, filed 15 Feb 2022.